Thierry Piéton is the Executive Vice President and Chief Financial Officer at Medtronic PLC, a global leader in medical technology and healthcare solutions. With over 25 years of experience in finance and strategic leadership, Piéton joined Medtronic in 2018, bringing a wealth of expertise from his previous roles in multinational corporations. Born in France and educated at the École Supérieure de Commerce de Paris (ESCP Business School), where he earned his master's degree in finance, Piéton began his career at a prominent European investment bank, honing his skills in corporate finance, mergers and acquisitions, and risk management. His international perspective, gained through assignments in Europe, Asia, and North America, has been instrumental in navigating complex global markets. Throughout his career, Piéton has achieved notable successes, including spearheading a major restructuring at a previous employer that resulted in a 20% increase in operational efficiency and significant cost savings. At Medtronic, he has played a pivotal role in driving financial strategy during periods of rapid innovation and expansion, such as overseeing the integration of key acquisitions that enhanced the company's portfolio in minimally invasive therapies and diabetes management. Under his leadership, Medtronic has maintained strong financial health, with consistent revenue growth and improved shareholder returns, even amid economic uncertainties. Piéton's commitment to sustainability and ethical financial practices has also earned him recognition, including being named one of the top CFOs in the healthcare sector by industry publications. In his current role, Piéton is responsible for overseeing Medtronic's global finance organization, including treasury, tax, investor relations, and financial planning. He collaborates closely with the executive team to align financial strategies with the company's mission of alleviating pain, restoring health, and extending life for millions worldwide. Looking ahead, Piéton is focused on leveraging emerging technologies like AI and data analytics to optimize financial operations and support Medtronic's ambitious growth targets in emerging markets. His strategic vision continues to position the company as a resilient and innovative force in the medtech industry.